abstract
- Therapeutic options for patients with metastatic renal cell carcinoma have significantly improved over the past few years with the recent approval of two new agents resulting in prolonged progression-free and overall survival.
Recent advances in the management of renal cell carcinoma.
Review
Overview
authors
publication date
- March 23, 2016
published in
- F1000Research Journal
Identity
PubMed Central ID
- PMC4806703
Scopus Document Identifier
- 84946607195
Digital Object Identifier (DOI)
- 10.1056/NEJMoa1510665
PubMed ID
- 27019698
Additional Document Info
has global citation frequency
volume
- 5